世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

India Chemotherapy at Home Service Market, By Product (Chemotherapy Drugs and Chemotherapy Infusion Pumps), By Treatment Stage (Early-Stage Cancer, Advanced-Stage Cancer, Metastatic Cancer, and Recurrent Cancer), By Cancer Type (Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer, and Others), By Distribution Channel (Home Health Agencies, Pharmacy-based Services, Direct-to-Patient Services, and Others), By Region, Competition, Forecast and Opportunities, 2029


The India chemotherapy at home service market is anticipated to witness impressive growth during the forecast period. This can be ascribed due to the growing demand for home healthcare service, and... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年10月3日 US$3,500
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
88 英語

 

Summary

The India chemotherapy at home service market is anticipated to witness impressive growth during the forecast period. This can be ascribed due to the growing demand for home healthcare service, and even COVID-19 pandemic has accelerated the demand for home healthcare services in India, as more people are seeking to avoid hospitals and clinics due to the risk of infection. This has led to increased interest in chemotherapy at home services, as they provide a safe and convenient option for cancer patients. Advances in technology have made it possible to provide high-quality chemotherapy at home services, including remote monitoring and consultation services. This has improved the accessibility and quality of care for cancer patients in India. The high cost of hospital-based treatment is a major concern for many cancer patients and their families in India. Chemotherapy at home services can be a cost-effective alternative, as they eliminate the need for hospitalization and reduce the overall cost of treatment. Cancer being the leading cause of death in India, the demand for chemotherapy at home services is increasing. The government of India has launched several initiatives to improve access to healthcare services in the country, including home healthcare services. Chemotherapy at home allows patients to receive treatment in the comfort of their own home, without having to travel to a hospital or clinic. This can be particularly beneficial for patients who live far away from treatment centers or have mobility issues.

Need For Cost-Effective Healthcare

The high cost of cancer treatment is a significant burden for many patients and their families in India, and chemotherapy is often one of the most expensive components of cancer care.
Chemotherapy at home services can be a cost-effective alternative to hospital-based treatment, as they eliminate the need for hospitalization and reduce the overall cost of treatment. Hospitalization can be a major cost driver in cancer care, as it involves expenses such as room charges, nursing care, and other ancillary services. By providing chemotherapy at home, healthcare providers can significantly reduce the cost of treatment and make it more accessible to patients who may not be able to afford hospital-based care. Also, home-based chemotherapy can reduce the indirect costs associated with hospitalization, such as lost wages, travel expenses, and childcare costs. Cost-effective healthcare is a priority for the government of India and several initiatives are being launched to improve access to affordable healthcare services in the country. Chemotherapy at home services provide patients with greater flexibility and convenience. Patients can receive treatment in the comfort of their own homes, without the need to travel to a hospital or clinic. This is particularly beneficial for patients who are elderly or have mobility issues, as well as those who live in rural areas and have limited access to healthcare facilities. The National Health Policy 2017, for example, aims to provide universal access to affordable healthcare services, including home-based care. By providing affordable and accessible cancer care, chemotherapy at home services can help improve outcomes for cancer patients and reduce the financial burden of cancer treatment. The need for cost-effective healthcare is a major driver of the chemotherapy at home service market in India.

New Technologies
The chemotherapy at home service market in India is experiencing technological advancements that are helping to improve the quality and effectiveness of chemotherapy treatment. Some of the new technologies that are being introduced in the market include mobile applications. Healthcare providers are using mobile applications to manage chemotherapy treatment plans for patients as these apps help providers to track patients' treatment progress, monitor symptoms, and communicate with patients and their caregivers.
Telemedicine is being used to provide remote consultations and support to patients receiving chemotherapy at home. This technology enables healthcare providers to monitor patients' health status, review test results, and adjust treatment plans as needed.
Wearable devices are being used to monitor patients' vital signs, track their physical activity levels, and monitor medication adherence. These devices can help healthcare providers to identify potential problems early on and make timely interventions to prevent complications.
Artificial intelligence (AI) is being used to analyze patient data and identify patterns that can help predict treatment outcomes. AI can also be used to identify patients who are at risk of developing complications and provide early interventions to prevent these complications from occurring. Remote monitoring systems are being used to provide real-time monitoring of patients' health status, including vital signs, and medication adherence. These systems enable healthcare providers to identify potential problems early on and make timely interventions to prevent complications. This factor will accelerate the growth of India chemotherapy at home service market.

Collaborations and Partnerships

Access to expertise and resources, collaborations and partnerships between service providers, pharmaceutical companies, and other healthcare organizations can provide access to specialized expertise, resources, and technology. This can help improve the quality of chemotherapy at home services and enhance the overall patient experience. Collaborations and partnerships can help service providers expand their services to new regions or areas of expertise. For example, partnerships with pharmaceutical companies can provide access to a wider range of chemotherapy drugs, while collaborations with other healthcare organizations can help service providers offer complementary services, such as home nursing care. Collaborations and partnerships can also help enhance research and development efforts in the field of chemotherapy at home services. This can lead to the development of new technologies and treatments, which can improve patient outcomes and help service providers stay competitive in the market. Collaborations and partnerships can help service providers increase their brand recognition and reputation within the healthcare industry. This can lead to increased patient trust and loyalty, which can help drive growth in the chemotherapy at home service market.
Market Segmentation

India chemotherapy at home service market can be segmented into by product, treatment stage, cancer type, distribution channel, and region. By product, India chemotherapy at home service market can be segmented into chemotherapy drugs and chemotherapy infusion pump. By treatment stage, India chemotherapy at home service market can be segmented into early-stage cancer, advanced-stage cancer, metastatic cancer, and recurrent cancer. By cancer type, India chemotherapy at home service market can be segmented into breast cancer, blood cancer, ovarian cancer, colorectal cancer, and others. By distribution channel, India chemotherapy at home service market can be segmented into home health agencies, pharmacy-based services, direct-to-patient services, and others. By Region, India chemotherapy at home service market can be segmented into North India, South India, East India, and West India.

Market Players

Health Care at Home India Pvt Ltd., PurpleRibbon Healthcare Services Pvt Ltd., HCG Oncology Healthcare Pvt Ltd, Zoctr Health Pvt Ltd., and Health Vista Pvt Ltd. (Portea Medical) are some of the market players in India chemotherapy at home service market.
Report Scope:
In this report, the India chemotherapy at home service market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Chemotherapy at Home Service Market, By Product:
o Chemotherapy Drugs
o Chemotherapy Infusion Pumps

• India Chemotherapy at Home Service Market, By Treatment Stage:
o Early-Stage Cancer
o Advanced-Stage Cancer
o Metastatic Cancer
o Recurrent Cancer

• India Chemotherapy at Home Service Market, By Cancer Type:
o Breast Cancer
o Blood Cancer
o Ovarian Cancer
o Colorectal Cancer

• India Chemotherapy at Home Service Market, By Distribution Channel:
o Home Health Agencies
o Pharmacy-based Services
o Direct-to-Patient Services

• India Chemotherapy at Home Service Market, By Region:
o North India
o South India
o East India
o West India

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present India chemotherapy at home service market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. India Chemotherapy at Home Service Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Chemotherapy Drugs and Chemotherapy Infusion Pumps)
5.2.2. By Treatment Stage (Early-Stage Cancer, Advanced-Stage Cancer, Metastatic Cancer, Recurrent Cancer)
5.2.3. By Cancer Type (Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer, Others)
5.2.4. By Distribution Channel (Home Health Agencies, Pharmacy-based Services, Direct-to-Patient Services, others
5.2.5. By Region (North India, South India, East India, West India)

6. North India Chemotherapy at Home Service Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Treatment Stage
6.2.3. By Cancer Type
6.2.4. By Distribution Channel

7. South India Chemotherapy at Home Service Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Treatment Stage
7.2.3. By Cancer Type
7.2.4. By Distribution Channel

8. East India Chemotherapy at Home Service Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Treatment Stage
8.2.3. By Cancer Type
8.2.4. By Distribution Channel

9. West India Chemotherapy at Home Service Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Treatment Stage
9.2.3. By Cancer Type
9.2.4. By Distribution Channel

10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition
11.2. Product Development
11.3. Recent Developments
12. Policy & Regulatory Landscape
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. India Economic Profile
15. Competitive Landscape
15.1. Business Overview
15.2. Company Snapshot
15.3. Products & Services
15.4. Financials (As Reported)
15.5. Recent Developments
15.5.1. Health Care at Home India Pvt Ltd.
15.5.2. PurpleRibbon Healthcare Services Pvt Ltd.
15.5.3. HCG Oncology Healthcare Pvt Ltd.
15.5.4. Zoctr Health Pvt Ltd.
15.5.5. Health Vista Pvt Ltd (Portea Medical)
16. Strategic Recommendations
17. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

TechSci Research 社の最新刊レポート

本レポートと同じKEY WORD(blood cancer)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/23 10:28

157.74 円

172.13 円

206.60 円

ページTOPに戻る